APOLLON INC has a total of 24 patent applications. Its first patent ever was published in 1993. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are HANGZHOU CONVERD CO LTD, HARBIN PHARMACEUTICAL GROUP BIO VACCINE CO LTD and INTROGEN THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Canada | 6 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 | |
#5 | Australia | 2 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Machines | |
#6 | Furniture and games | |
#7 | Weapons |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Sugars | |
#6 | Climate change adaptation technologies | |
#7 | Measuring microorganism processes | |
#8 | Office furniture | |
#9 | Unspecified technologies | |
#10 | Armour |
# | Name | Total Patents |
---|---|---|
#1 | Pachuk Catherine J | 11 |
#2 | Coney Leslie R | 10 |
#3 | Carrano Richard A | 5 |
#4 | Satishchandran C | 4 |
#5 | Tokushige Katsutoshi | 4 |
#6 | Yoon Kyonggeun | 4 |
#7 | Wakita Takaji | 4 |
#8 | Wands Jack | 4 |
#9 | Zurawski Vincent R Jr | 4 |
#10 | Wang Bin | 3 |
Publication | Filing date | Title |
---|---|---|
KR20160089135A | Bulletproof speech table | |
AU2033699A | Hepatitis virus vaccines | |
US5851804A | Chimeric kanamycin resistance gene | |
CA2202088A1 | Hepatitis virus vaccines | |
US5962428A | Compositions and methods for delivery of genetic material | |
CA2178811A1 | Anti-hepatitis b viral oligonucleotides | |
US5739118A | Compositions and methods for delivery of genetic material | |
WO9417086A1 | Gene regulation by targeting putative intramolecular triple helix | |
EP0674707A1 | Compounds and methods for the treatment of leukemias. | |
WO9407367A1 | Anti-viral oligomers that bind polypurine tracts of single-stranded rna or rna-dna hybrids |